Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Osama M. Ghogar"'
Autor:
Mahmoud M. Ali, Ahmed Hafez, Mahmoud Shaban Abdelgalil, Mohammed Tarek Hasan, Mohammed Magdy El-Ghannam, Osama M. Ghogar, Asmaa Ahmed Elrashedy, Mohamed Abd-ElGawad
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-16 (2022)
Abstract Background The food and drug administration approved many drugs to treat diabetes mellitus, but those drugs do not have a noticeable effect on weight management. Recently, glucagon-like peptide 1 agonist known as Cotadutide serve as a potent
Externí odkaz:
https://doaj.org/article/5a96cc484f8743379a834049255cd8c1
Autor:
Fares E.M Ali, Islam M. Ibrahim, Osama M Ghogar, Esraa K. Abd-alhameed, Hanan S. Althagafy, Emad H.M. Hassanein
Publikováno v:
World Journal of Gastroenterology. 29:1026-1053
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed4b8f49fc831f96ee47582af80b3387
https://doi.org/10.3748/wjg.v29.i6.1026
https://doi.org/10.3748/wjg.v29.i6.1026
Publikováno v:
World Journal of Gastroenterology. 29:425-449
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4642124b23731d698cde143e88593e0b
https://doi.org/10.3748/wjg.v29.i3.425
https://doi.org/10.3748/wjg.v29.i3.425
Publikováno v:
World Journal of Gastroenterology
Coronavirus disease 2019 (COVID-19) is a devastating worldwide pandemic infection caused by a severe acute respiratory syndrome namely coronavirus 2 (SARS-CoV-2) that is associated with a high spreading and mortality rate. On the date this review was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddc05c74883658d7c78a0a0074b2e673
https://doi.org/10.3748/wjg.v27.i15.1531
https://doi.org/10.3748/wjg.v27.i15.1531
Autor:
Khalid M Eid, Abdulrahman H Almaeen, Ahmed H E Ghoziz, Nashwa A M Mostafa, Heba M. Saad Eldien, Fares E.M. Ali, Mohamed G Hagag, Osama M Ghogar, Mohamed R A Marzouk, Abdelaziz F Ebrahiem
Publikováno v:
Current Molecular Pharmacology. 14:88-100
Objective: The present study was conducted to elucidate the underlying molecular mechanism as well as the potential hepatoprotective effects of royal jelly (RJ) against hepatic ischemia/reperfusion (IR) injury. Methods: Rats were assigned into four g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f5fd68a45fe60f6952b0b285549cdf3
https://doi.org/10.2174/1874467213666200514223829
https://doi.org/10.2174/1874467213666200514223829
Autor:
Mahmoud M Ali, Ahmed Hafez, Mahmoud Shaban Abdelgalil, Mohammed Tarek Hasan, Mohammed Magdy El-Ghannam, Osama M Ghogar, Asmaa Ahmed Elrashedy, Mohamed Abd-ElGawad
Background: The food and drug administration approved many drugs to treat diabetes mellitus, but those drugs do not have a noticeable effect on weight management. Recently, glucagon-like peptide 1 agonist known as Cotadutide was estimated to serve as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8615132e03c5f18a96159271f73f290
https://doi.org/10.21203/rs.3.rs-1236048/v1
https://doi.org/10.21203/rs.3.rs-1236048/v1
